Drug Shortage Report for CLAVULIN 250 F ORAL SUS
Report ID | 166417 |
Drug Identification Number | 01916874 |
Brand name | CLAVULIN 250 F ORAL SUS |
Common or Proper name | amoxicillin / clavulanate potassium for oral suspension |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | CLAVULANIC ACID AMOXICILLIN |
Strength(s) | 62.5MG 250MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 100ML |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-08-05 |
Estimated end date | 2022-11-30 |
Actual end date | 2022-10-26 |
Shortage status | Resolved |
Updated date | 2022-10-27 |
Company comments | Supply released October 14, 2022 with limited quantity. Inventory on allocation to support demand. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2022-10-27 | English | Compare |
v10 | 2022-10-26 | French | Compare |
v9 | 2022-10-26 | English | Compare |
v8 | 2022-10-21 | French | Compare |
v7 | 2022-10-21 | English | Compare |
v6 | 2022-10-12 | French | Compare |
v5 | 2022-10-12 | English | Compare |
v4 | 2022-09-14 | French | Compare |
v3 | 2022-09-14 | English | Compare |
v2 | 2022-08-10 | French | Compare |
v1 | 2022-08-10 | English | Compare |
Showing 1 to 11 of 11